 |
 | Services
| |
 |
Aliases & Descriptions for BRAF
(According to
1HGNC,
2Entrez Gene,
3UniProtKB/Swiss-Prot,
4UniProtKB/TrEMBL, 5OMIM, 6GeneLoc
, and/or 7Ensembl,
8miRBase) About This Section
|
| Aliases |
|---|
| B-RAF1 2 | | B-Raf 2 | | BRAF1 1, 2, 3 | | EC 2.7.11.1 3 | | FLJ95109 2 | | MGC126806 2 | | MGC138284 2 | | RAFB1 2, 3 | | p94 3 |
| | | Descriptions |
|---|
| 94 kDa B-raf protein 2 | | B-Raf proto-oncogene serine/threonine-protein kinase (p94) 2 | | murine sarcoma viral (v-raf) oncogene homolog B1 2 | | v-raf murine sarcoma viral oncogene homolog B1 2, 3 |
|
| | Search outside databases for aliases for BRAF genePrevious GC identifers: GC07M138705 GC07M139764 GC07M139841 GC07M139754 GC07M139887 |
Summaries for BRAF(According to Entrez Gene,
Wikipedia's
Gene Wiki,
UniProtKB/Swiss-Prot,
and/or
UniProtKB/TrEMBL)
About This Section
| EntrezGene summary for BRAF: This gene encodes a protein belonging to the raf/mil family of serine/threonine protein kinases. This protein plays a role in regulating the MAP kinase/ERKs signaling pathway, which affects cell division, differentiation, and secretion. Mutations in this gene are associated with cardiofaciocutaneous syndrome, a disease characterized by heart defects, mental retardation and a distinctive facial appearance. Mutations in this gene have also been associated with various cancers, including non-Hodgkin lymphoma, colorectal cancer, malignant melanoma, thyroid carcinoma, non-small cell lung carcinoma, and adenocarcinoma of lung. A pseudogene, which is located on chromosome X, has been identified for this gene. [provided by RefSeq] UniProtKB/Swiss-Prot: BRAF1_HUMAN, P15056Function: Involved in the transduction of mitogenic signals from the cell membrane to the nucleus. May play a role in the postsynaptic responses of hippocampal neuronGene Wiki entry for BRAF |
Genomic Location for BRAF
(According to
GeneLoc and/or
HGNC, and/or
Entrez Gene (NCBI build 36),
and/or miRBase,
Genomic Views according to
UCSC and
Ensembl,
Transcription factor binding sites according to
SABiosciences) About This Section
| Genomic View: UCSC Golden Path with GeneCards custom track
Transcription factor binding sites upstream to the BRAF gene 
Entrez Gene cytogenetic band: 7q34 Ensembl cytogenetic band: 7q34 HGNC cytogenetic band: 7q34BRAF Gene in genomic location: bands according to Ensembl, locations according to
(and/or Entrez Gene and/or Ensembl if different)
 GeneLoc gene densities for chromosome 7 GeneLoc Exon Structure GeneLoc location for GC07M140080:
(about GC identifiers)
Start:
|
140,080,751 bp from pter |
End:
|
140,271,033 bp from pter |
Size:
|
190,283 bases |
Orientation:
|
minus strand |
1 alternative location:
| Chr7-,CRA_TCAG 139,772,459-139,962,886 |
RefSeq DNA sequence:- NC_000007.12 NT_007914.14 NT_079596.2
| Proteins for BRAF
(According to
1UniProtKB,
and/or Ensembl,
Phosphorylation sites according to 2Phosphosite,
RefSeq according to NCBI,
PDB rendering according to OCA and/or Proteopedia,
Recombinant Proteins
from Invitrogen,
Millipore,
Sigma-Aldrich,
R&D Systems,
Enzo Life Sciences,
Abnova,
OriGene and/or,
Abcam,
Biochemical Assays by
Invitrogen,
Millipore,
R&D Systems,
Cell Signaling Technology, and/or
Enzo Life Sciences,
Ontologies according to Gene
Ontology Consortium 01 Apr 2009 and
Entrez Gene,
Antibodies by Invitrogen,
Millipore,
Sigma-Aldrich,
R&D Systems,
Cell Signaling Technology,
Abcam,
Abnova, and/or
Novus Biologicals)
About This Section
| UniProtKB/Swiss-Prot: BRAF1_HUMAN, P15056 (See
protein sequence)Recommended Name: B-Raf proto-oncogene serine/threonine-protein kinase Size: 766 amino acids; 84437 Da
Cofactor: Binds 2 zinc ions per subunit (By similarity)
Subunit: Interacts with RIT1 (By similarity)
Subcellular location: Cytoplasm
Sequence caution: Sequence=AAD43193.1; Type=Erroneous gene model prediction;
PDB structures from and Proteopedia :1UWH (3D)
 1UWJ (3D)
 2FB8 (3D)
 3C4C (3D)
 3C4D (3D)
 3D4Q (3D)
 
Secondary accessions: Q13878 Q3MIN6 Q9UDP8 Q9Y6T3Post-translational modifications:
View phosphorylation sites using PhosphoSite2
REFSEQ proteins: NP_004324.2
ENSEMBL proteins: ENSP00000288602
Human Recombinant Proteins               OriGene Purified Recombinant Human Protein: BRAF 
2 Gene Ontology (GO) cellular component terms (links to tree view): About this table
Antibodies for BRAF:  | Invitrogen Antibodies for BRAF |  | Millipore Mono- and Polyclonal Antibodies for the study of BRAF |  | Sigma-Aldrich Antibodies for BRAF |  | R&D Systems Antibodies for BRAF (B-Raf) |  | Cell Signaling Technology (CST) Antibodies for BRAF  (B-Raf) |  | Antibodies from Abcam (B Raf), each with their AbpromiseSM |  | Monoclonal and Polyclonal Antibodies from Abnova (BRAF) |  | Novus Biologicals Antibodies for BRAF |
Assays for BRAF: | Protein
Domains/ Families for BRAF(According to InterPro, ProtoNet,
UniProtKB, and/or BLOCKS,
Sets of similar genes according to GeneDecks)
About This Section
| - Graphical View of Domain Structure for InterPro Entry P15056
ProtoNet protein and cluster: P15056 2 Blocks protein families: IPB002219 Protein kinase C IPB003116 Raf-like Ras-binding
UniProtKB/Swiss-Prot: BRAF1_HUMAN, P15056Similarity: Belongs to the protein kinase superfamily. TKL Ser/Thr protein kinase family. RAF subfamilySimilarity: Contains 1 phorbol-ester/DAG-type zinc fingerSimilarity: Contains 1 protein kinase domainSimilarity: Contains 1 RBD (Ras-binding) domain | Gene Function for BRAF
(According to MGI Jun 06 2009, UniProtKB,
IUBMB,and/or Genatlas,
shRNA from
OriGene,
Sigma-Aldrich, RNAi from
Sigma-Aldrich,
RNAi Products,
Clones, and
Q-PCR Products
from Invitrogen,
Millipore,
OriGene, and/or
Abnova,
siRNAs from
Applied Biosystems,
SYBR primers from OriGene,
Cell-based Assays from Millipore,
Ontologies according to Gene Ontology Consortium 01 Apr 2009 via
Entrez Gene.)
About This Section
| Inhib. RNA: |  | Invitrogen RNAi Products for gene knock-down (BRAF) | |  | Millipore RNAi Products for the Analysis of BRAF Gene knock-down | |  | Abnova Chimera RNAi Products for Gene knock-down (BRAF) |               OriGene 29mer shRNA kit in GFP-retroviral vector: NM_004333
Applied Biosystems Silencer® siRNAs for BRAF
Sigma-Aldrich siRNA and siRNA Panels for BRAF  Sigma-Aldrich shRNA Panels and shRNA for BRAF  Explore Sigma-Aldrich super-pooled esiRNAs 
              OriGene GFP tagged cDNA clone in CMV expression vector: NM_004333                                  Myc/DDK tagged cDNA clone in CMV expression vector: NM_004333                                  untagged cDNA clone in CMV expression vector: NM_004333 
Primers: Browse
Quantitative PCR Central at Invitrogen for Q-PCR LUX™ Primers               OriGene genome-wide validated SYBR primer pairs: NM_004333
UniProtKB/Swiss-Prot: BRAF1_HUMAN, P15056Function: Involved in the transduction of mitogenic signals from the cell membrane to the nucleus. May play a role in the postsynaptic responses of hippocampal neuronCatalytic activity: ATP + a protein = ADP + a phosphoproteinEnzyme Number (IUBMB): EC 2.7.11.1 Genatlas biochemistry entry for BRAF:murine sarcoma 3611 viral (v-raf) oncogene homolog B1 (Rmil),expressed in cerebrum and testis,fused with TIF1A to form the oncoprotein T1815/20 MGI mutant phenotypes (inferred from 8 alleles ) (MGI details for Braf) (see all 20
):
5/9 Gene Ontology (GO) molecular function terms (links to tree view) (see all 9
): About this table | Pathways & Interactions for BRAF
(Pathways according to Invitrogen
(maps by GeneGo),
Millipore,
Cell Signaling Technology,
Sigma-Aldrich,
KEGG
and/or UniProtKB,
Sets of similar genes according to GeneDecks,
Proteins Network according to
SABiosciences,
Interactions according to 1UniProtKB,
2MINT, and/or
3STRING,
with links to IntAct and
Ensembl,
Ontologies according to Gene Ontology Consortium 01 Apr 2009 via
Entrez Gene.)
About This Section
|
5/16 Sigma-Aldrich "Your Favorite Gene" Pathways for BRAF (Your Favorite Gene powered by Ingenuity) (see all 16
) 
Gene Network CentralTM Interacting Genes and Proteins Network for BRAF 
5/93 Interacting proteins for BRAF (ENSP000002886023 P150561, 2) via UniProtKB, MINT, and/or STRING (see all 93
)| Interactant | Interaction Details |
|---|
| GeneCard | External ID(s) |
|---|
| PRKCA | P172522 | STRING (score=.952) MINT-2833162 | | YWHAZ | P631041, 2 | STRING (score=.801) EBI-365980, EBI-347088 MINT-3295552 MINT-51024 EBI-365980, EBI-347088 MINT-3295552 MINT-51024 | | YWHAB | P319461, 2 | STRING (score=.99) EBI-365980, EBI-359815 MINT-50344 EBI-365980, EBI-359815 MINT-50344 | | YWHAQ | P273481, 2 | STRING (score=.752) EBI-365980, EBI-359854 MINT-50372 EBI-365980, EBI-359854 MINT-50372 | | YWHAG | P619811, 2 | EBI-365980, EBI-359832 MINT-50888 EBI-365980, EBI-359832 MINT-50888 | About this table
4 Gene Ontology (GO) biological process terms (links to tree view): About this table
|
Drugs & Compounds for BRAF(Chemical Compounds according to UniProtKB, Enzo Life Sciences,
Sigma-Aldrich, Tocris Bioscience, and/or
Novoseek and Drugs according to
Enzo Life Sciences and/or
PharmGKB)
About This Section
|
Compounds for BRAF available from Tocris Bioscience
| Compound | Action |
CAS
number |
|---|
| ZM 336372 | Potent, selective c-Raf inhibitor | [208260-29-1] | | GW 5074 | Potent, selective c-Raf1 kinase inhibitor | [220904-83-6] | | L-779,450 | Potent Raf kinase inhibitor | [303727-31-3] | About this table
10/32 Novoseek chemical compound relationships for BRAF gene (see all 32
)
| Compound |
Score |
Articles |
PubMed IDs for Articles with Shared Sentences (# sentences) |
| crcs |
76.28 |
18 |
19147861 (2), 18435933 (2), 15542810 (2), 14639609 (1) (see all 12) |
| gw-5074 |
63.91 |
11 |
18194435 (5), 16314406 (1), 15255937 (1) |
| 17-(allylamino)-17-demethoxygeldanamycin |
62.63 |
10 |
18375819 (2), 16371460 (1), 18281615 (1), 18676857 (1) |
| threonine |
61.53 |
37 |
8557035 (1), 14508525 (1), 19206169 (1), 1630826 (1) (see all 31) |
| o6-methylguanine |
52.14 |
5 |
17867575 (1), 18300810 (1), 15616773 (1), 16118624 (1) (see all 5) |
| phosphatidylinositol |
41.15 |
6 |
15263001 (2), 8576262 (1), 17183069 (1), 19118027 (1) (see all 5) |
| tyrosine |
40.80 |
24 |
10205168 (2), 9020159 (2), 12446733 (2), 9844921 (1) (see all 16) |
| sodium iodide |
40.02 |
1 |
16254036 (1) |
| pd 98,059 |
31.91 |
6 |
17709622 (3), 18194435 (1), 17424890 (1), 15705790 (1) (see all 6) |
| thymine |
30.84 |
10 |
15968271 (1), 15641040 (1), 16708643 (1), 15126572 (1) (see all 8) |
About this table
|
Transcripts for BRAF(GenBank/EMBL/DDBJ Accessions according to
Unigene
(Build 219 Homo sapiens; Jun 2 2009) or GenBank, RefSeq according to Entrez Gene,
DOTS (version 10), and/or
AceView,
non coding RNAs according to
RNAdb,
ESTs according to GeneTide,
exon structure from GeneLoc,
alternative splicing isoforms according to ASD and/or
ECgene,
RNAi Products from Invitrogen,
Millipore, and/or
Abnova,
siRNAs from Applied Biosystems,
Sigma-Aldrich,
shRNA from
Sigma-Aldrich,
OriGene,
Tagged/untagged cDNA clones from
OriGene, Expression Assays from Applied Biosystems) About This Section
| Inhib. RNA: |  | Invitrogen RNAi Products for gene knock-down (BRAF) | |  | Millipore RNAi Products for the Analysis of BRAF Gene knock-down | |  | Abnova Chimera RNAi Products for Gene knock-down (BRAF) |               OriGene 29mer shRNA kit in GFP-retroviral vector: NM_004333
Sigma-Aldrich siRNA and siRNA Panels for BRAF  Sigma-Aldrich shRNA Panels and shRNA for BRAF  Explore Sigma-Aldrich super-pooled esiRNAs 
Applied Biosystems Silencer® siRNAs: NM_004333 REFSEQ mRNAs for BRAF gene: NM_004333.4
Applied Biosystems TaqMan ® Gene Expression Assays: NM_004333               OriGene GFP tagged cDNA clone in CMV expression vector: NM_004333                                  Myc/DDK tagged cDNA clone in CMV expression vector: NM_004333                                  untagged cDNA clone in CMV expression vector: NM_004333  Additional cDNA sequence: AK314346.1 BC038966.1 BC101757.1 BC112079.1 M21001.1 M95712.2 8 DOTS entries: DT.412400 DT.95121279 DT.92070713 DT.121078775 DT.75172532 DT.121078703 DT.40105916 DT.445289 24/151 AceView cDNA sequences (see all 151
):CA396753 BF089752 BQ771705 BM684937 BE620440 AI040223 BX280711 AL135067 AA812678 AK098095 AA705424 AI384098 AI635384 AA279937 BM931879 AA907838 AI378370 BU742293 AI435611 AU118767 CB241287 AA679780 AA905230 AW613053
highest scoring ESTs for BRAF:M95712 AA741481 AI018295 AI203435 AL039290 AW295124 AA252274 AA262800 AA805671 AA815165 Unigene Cluster for BRAF: V-raf murine sarcoma viral oncogene homolog B1 Hs.550061 [show with all ESTs]Unigene Representative Sequence: NM_004333
GeneLoc Exon Structure
1 Ensembl transcript including schematic representation: ENST00000288602
|
Expression for BRAF
(Experimental results according to
1GeneNote
and GNF BioGPS,
probe sets-to-genes annotations according to
2GeneAnnot ,
3GeneTide ,
Sets of similar genes according to GeneDecks,
Electronic Northern calculations according to data from
UniGene (Build 219 Homo sapiens),
SAGE tags according to
CGAP,
plus additional links to
SOURCE, and/or
GNF
BioGPS, and/or
EXPOLDB, and/or
UniProtKB,
Expression Assays from
Applied Biosystems
)
About This Section
| BRAF expression in normal and diseased human tissues
Applied Biosystems TaqMan ® Gene Expression Assays for BRAF
1 / 2 / 3 7 probe-sets matching BRAF gene Data from
(Publications) and GNF BioGPS About these images About these images
CGAP SAGE TAG: AAGAGATTAA
SOURCE GeneReport for Unigene cluster: Hs.550061
Expression variation in blood from EXPOLDB for BRAF UniProtKB/Swiss-Prot: BRAF1_HUMAN, P15056Tissue specificity: Brain and testis |
Orthologs for BRAF
(Orthologs according to
1,2HomoloGene (2older version, for species not in 1newer version),
3euGenes,
4SGD
and/or
5MGI Jun 06 2009,
with possible further links to
Flybase
and/or
WormBase,
Gene Trees according to Ensembl)
About This Section
|
Orthologs for BRAF gene from 5/13 species (see all 13
)
About this table Species with no ortholog for BRAF
ENSEMBL Gene Tree for BRAF | Paralogs for BRAF(Paralogs according to 1HomoloGene and 2Ensembl, Pseudogenes according to 3Pseudogene.org) About This Section
| Paralogs for BRAF gene
- ARAF2 RAF12
|
SNPs/Variants for BRAF(According to the
1NCBI SNP Database,
2Ensembl,
3PupaSUITE, and
UniProtKB,
Linkage Disequilibrium by HapMap,
Genotyping Reagents from
Applied Biosystems)
About This Section
|
HapMap Linkage Disequilibrium images for BRAF (up to first 250kb)
|
Disorders & Mutations for BRAF
(in which this Gene is Involved, According to
OMIM, UniProtKB,
Novoseek, PharmGKB,
Genatlas, GeneTests,
Blood group antigen gene mutations by BGMUT,
HGMD, GAD,
HuGE Navigator,
BCGD,
and/or TGDB.)
About This Section
|
OMIM: 164757 UniProtKB/Swiss-Prot: BRAF1_HUMAN, P15056
Defects in BRAF are a cause of cardiofaciocutaneous syndrome (CFC syndrome) [MIM:115150]; also known as cardio-facio-cutaneous syndrome. CFC syndrome is characterized by a distinctive facial appearance, heart defects and mental retardation. Heart defects include pulmonic stenosis, atrial septal defects and hypertrophic cardiomyopathy. Some affected individuals present with ectodermal abnormalities such as sparse, friable hair, hyperkeratotic skin lesions and a generalized ichthyosis-like condition. Typical facial features are similar to Noonan syndrome. They include high forehead with bitemporal constriction, hypoplastic supraorbital ridges, downslanting palpebral fissures, a depressed nasal bridge, and posteriorly angulated ears with prominent helices. The inheritance of CFC syndrome is autosomal dominant Defects in BRAF are involved in a wide range of cancers Defects in BRAF are involved in lung cancer [MIM:211980] Defects in BRAF are involved in non-Hodgkin lymphoma (NHL) [MIM:605027]. NHL is a cancer that starts in cells of the lymph system, which is part of the body's immune system. NHLs can occur at any age and are often marked by enlarged lymph nodes, fever and weight loss Defects in BRAF may be a cause of colorectal cancer (CRC) [MIM:114500]10/96 Novoseek disease relationships for BRAF gene (see all 96
)
| Disease |
Score |
Articles |
PubMed IDs for Articles with Shared Sentences (# sentences) |
| thyroid papillary carcinoma |
90.60 |
135 |
15968271 (6), 17060774 (4), 15095090 (2), 16452550 (2) (see all 96) |
| cfc syndrome |
89.44 |
14 |
18651097 (2), 17366577 (2), 17551924 (2), 19206169 (1) (see all 10) |
| microsatellite instability |
87.39 |
79 |
16403224 (4), 18718023 (3), 15221372 (2), 18517279 (2) (see all 64) |
| papillary thyroid cancer |
86.23 |
49 |
16487015 (3), 16174717 (2), 12970315 (2), 16708643 (2) (see all 34) |
| melanoma |
84.94 |
739 |
15824163 (9), 15917418 (8), 17699719 (8), 15060100 (7) (see all 99) |
| somatic mutations |
80.22 |
50 |
16567964 (2), 14688025 (2), 14612909 (1), 15093535 (1) (see all 43) |
| thyroid carcinoma anaplastic |
78.75 |
18 |
15195111 (7), 16533790 (2), 15880523 (1), 17878251 (1) (see all 9) |
| thyroid cancer |
77.38 |
53 |
17878251 (5), 12970315 (3), 17179987 (3), 17911174 (2) (see all 31) |
| colorectal cancer |
75.39 |
163 |
14734469 (7), 17924122 (6), 15782118 (5), 15340260 (5) (see all 77) |
| nevi |
73.35 |
108 |
16799476 (6), 15009715 (5), 15824163 (4), 15330192 (4) (see all 38) |
About this table
1 PharmGKB disease relationship for BRAF geneAbout this table
GeneTests: BRAF Cardiofaciocutaneous Syndrome Human Gene Mutation Database: BRAF Genetic Association Database: BRAF Human Genome Epidemiology Navigator: BRAF (108 documents)
|
Medical News for BRAF(Possibly Related Articles in
Doctor's Guide)
About This Section
| |
Publications for BRAF (in
PubMed.
Associations of this gene to articles via
1Novoseek,
2HGNC,
3Entrez Gene,
4UniProtKB/Swiss-Prot,
5UniProtKB/TrEMBL,
6GAD, and/or
7PharmGKB)
About This Section
| 10/1036 PubMed articles for BRAF gene (see all 1036
):- Complete coding sequence of a human B-raf cDNA and detection of B-raf protein kinase with isozyme specific antibodies. (PubMed id 2284096)2, 3, 4 Sithanandam G.... Rapp U.R. (1990)
- BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer. (PubMed id 16174717)1, 3, 6 Xing M....Ladenson P.W. (2005)
- BRAF mutations in non-Hodgkin's lymphoma. (PubMed id 14612909)1, 3, 4 Lee J.W.... Lee S.H. (2003)
- No Evidence for BRAF as a melanoma/nevus susceptibility gene. (PubMed id 15824163)1, 3, 6 Jackson S....Newton Bishop J.A. (2005)
- BRAF gene is somatically mutated but does not make a major contribution to malignant melanoma susceptibility: the Italian Melanoma Intergroup Study. (PubMed id 14722037)1, 3, 6 Casula M....Palmieri G. (2004)
- BRAF mutation in endometrial carcinoma and hyperplasia: correlation with KRAS and p53 mutations and mismatch repair protein expression. (PubMed id 16144912)1, 3, 6 Feng Y.Z....Konishi I. (2005)
- Mutations of the BRAF gene in papillary thyroid carcinoma and in Hashimoto's thyroiditis. (PubMed id 16143028)1, 3, 6 Kim K.H....Kang D.Y. (2005)
- BRAF polymorphisms and risk of melanocytic neoplasia. (PubMed id 16354196)1, 3, 6 James M.R....Duffy D.L. (2005)
- BRAF and NRAS mutations are frequent in nodular melanoma but are not associated with tumor cell proliferation or patient survival. (PubMed id 16098042)1, 3, 6 Akslen L.A....Kumar R. (2005)
- Uncommon V599E BRAF mutations in Japanese patients with lung cancer. (PubMed id 16376942)1, 3, 6 Sasaki H....Fujii Y. (2006)
|
Search for BRAF
(in PubMed,
OMIM, and NCBI Bookshelf) About This Section
|
|
Genome Databases showing BRAF
(According to
Entrez Gene,
HGNC,
AceView,
euGenes,
Ensembl,
miRBase,
ECgene,
and/or
H-InvDB)
About This Section
|
| Other Databases showing BRAF
(According to HUGE)
About This Section
| -- |
Specialized Databases showing BRAF(According to ATLAS, HORDE, IMGT, MTDB, LEIDEN, UniProtKB/Swiss-Prot, and/or UniProtKB/TrEMBL, Wikipedia and/or GeneReviews via UniProtKB/Swiss-Prot) About This Section
|
| About This Section
| --
| Services for BRAF(Reagents available from Applied Biosystems, Antibodies and assays by Cell
Signaling Technology, Abcam, Novus Biologicals, Sigma-Aldrich, R&D Systems, Millipore, Abnova, and/or Invitrogen, Clones available from OriGene,and/or Invitrogen, Drugs and/or compounds by Sigma-Aldrich, Enzo Life Sciences, and/or Tocris Bioscience) About This Section
| 
 Products for BRAF:

 | |
 | | | | |
|
 |  |  |
| Antibodies & Assays for BRAF  (B-Raf) |
| | | | Tocris compounds for BRAF |
|
 |
 | | | |
GeneCards Homepage - Last full update: 2 Jul 2009
Incremental update: 13 Oct 2009
|